Dashboard
Manage Tickers

BNTC


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

leerink-partners-initiates-coverage-on-benitec-biopharma-with-outperform-rating-announces-price-target-of-13
Leerink Partners Initiates Coverage On Ben...
07/22/2024 10:28:59

Leerink Partners analyst Mani Foroohar initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and an...

piper-sandler-initiates-coverage-on-benitec-biopharma-with-overweight-rating-announces-price-target-of-30
Piper Sandler Initiates Coverage On Benite...
06/13/2024 09:29:47

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Overweight rating and anno...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/13/2024 16:31:04

benitec-biopharma-q3-2024-revenue-0-down-from-54000-yoy
Benitec Biopharma Q3 2024 Revenue $0 Down ...
05/13/2024 12:19:12

Revenue $0 Down From

benitec-biopharma-q3-2024-gaap-eps-164-misses-078-estimate
Benitec Biopharma Q3 2024 GAAP EPS $(1.64)...
05/13/2024 12:18:48

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $...

benitec-biopharma-13g-filing-shows-steven-oliveira-reported-a-889-passive-stake-in-the-co-as-of-april-22
Benitec Biopharma 13G Filing Shows Steven ...
04/29/2024 15:48:49

- SEC Filing

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-16
JMP Securities Maintains Market Outperform...
04/22/2024 16:17:56

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

why-is-gene-therapy-developer-benitec-biopharma-stock-trading-higher-on-thursday
Why Is Gene Therapy Developer Benitec Biop...
04/18/2024 17:04:45

Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces inte...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

benitec-biopharma-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-29
Benitec Biopharma Shares Halted On Circuit...
04/18/2024 13:39:57

Core News & Articles
Market-Moving News for April 18th
04/18/2024 12:35:31

BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

benitec-biopharma-reports-interim-clinical-trial-data-for-first-opmd-subject-treated-with-bb-301-in-phase-1b2a-study-says-bb-301-facilitated-improvements-across-multiple-measures-of-swallowing-function-in-the-first-phase-1b2a-clinical-study-subject-as-compared-to-pretreatment-assessments-conducted-during-the-observational-natural-history-portion-of-the-study
Benitec Biopharma Reports Interim Clinical...
04/18/2024 11:32:18

benitec-biopharma-reports-oversubscribed-private-placement-financing-of-40m
Benitec Biopharma Reports Oversubscribed P...
04/18/2024 11:12:29

Benitec Biopharma announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5.749 million...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/04/2024 17:34:40

benitec-biopharma-files-for-mixed-shelf-of-up-to-125m
Benitec Biopharma Files For Mixed Shelf Of...
02/23/2024 21:14:56

-SEC Filing

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-10
JMP Securities Maintains Market Outperform...
02/15/2024 18:58:07

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

benitec-biopharma-q2-eps-264-up-from-334-yoy
Benitec Biopharma Q2 EPS $(2.64) Up From $...
02/13/2024 13:06:12

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.64) per share. This is a 20.96 percent increase over losses of...

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-8
JMP Securities Maintains Market Outperform...
01/24/2024 17:14:51

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION